Global CHA Network

CHA Medical Group

Global CHA Network
The global network of CHA Medical Group

About CHA health systems

In 1960, Dr. Cha started an Ob⁄Gyn clinic, which today has become the CHA Medical Group ,which operates 11 general hospitals with some 2,000 in-patient beds in Korea and Los Angeles. The CHA School of Medicine and various research institutes are also part of the CHA Medical Group.

Global CHA health systems Network

As a pioneer and global leader in stem cell therapy, CHA Medical Group conducts a wide range of research involving stem cells and new medical technologyies in order to contribute to the protection and promotion of human health.

First in Asia
1993 First successful intracytoplasmic sperm injection
1987 First successful pregnancy in a woman without ovum
First in Korea
2011 Approval for clinical trial using embryonic stem cells to Stargardt’s Disease or Age-related Macular Degeneration
2000 Establishment of CHA Bio &Diostech to conduct stem cell therapeutic research
First medical center to conduct joint research with academia
1994 Successful pregnancy after Microsurgical Tubal Reversal
1988 Laparoscopic surgery
1986 ZIFT (Zygote Intra-Fallopian Transfer)birth
1986 IVF (In Vitro Fertilization) birth
1985 GIFT (Gamete Intra- Fallopian Transfer)

First in World
2014 World’s first human somatic cell nuclear transfer using adult cells
2009 Successful treatment of cerebral palsy using autologous umbilical cord blood cells
2005 Development of oocytes cryopreservation technique using slush nitrogen/ ASRM Award
1998 Discovery of oocytesvitrification with grid using liquid nitrogen/ ASRM Award
1988 Successful pregnancy after in vitro fertilization of immature oocytes collected from
non-stimulated cycles/ ASRM Award

Achievements of CHA Medical Group introduced in the Time Magazine

1991 – Outcome of CHA’s research on infertility and reproductive medicine introduced as the cover topic	1994 – Outcome of CHA’s research introduced in the medical column	1996 - CHA’s research on infertility and immature oocyes reported as feature story oocytes

World’s first human somatic cell nuclear transfer using adult cells	First successful treatment of cerebral palsy using autologous umbilical cord blood cells.	First successful attempt at cerebral palsy treatment using allogeniec cord blood stem cells

Global Network

CHA Medical Group opened Stem Cell & Regenerative Medicine International which specializes in stem cell research in Boston and Los Angeles and the CHA Regenerative Medical Institute which combines stem cell research with regenerative medicine.

A wide range of research across the CHA global network culminated in the development of immunotherapy at the Tokyo Cell Clinic. Currently, clinical trials on immunotherapy that target various carcinoma are ongoing at the Hollywood Presbyterian Medical Center in LA as well as five hospitals in Korea that are part of the CHA Medical Group.

In addition, CHA Medical Group is in the process of developing cellular therapy based on stem cells. Working in close partnership with academia and other medical institutes, CHA Medical Group continuously strives to develop advanced technology ranging from cell culture to cellular therapies, and regenerative medicine.

한국 분당차병원,강남차병원,차움 병원 연구소